Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-08-29
2009-06-09
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S269000, C544S319000, C544S326000, C544S320000
Reexamination Certificate
active
07544688
ABSTRACT:
The invention provides compounds of Formula (I) or a pharmaceutically acceptable salt or ester thereof wherein the symbols have meaning as defined, which are inhibitors of cathepsin K and find use pharmaceutically for treatment of diseases and medical conditions in which cathepsin K is implicated, e.g. various disorders including inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors.
REFERENCES:
patent: 2002/0052378 (2002-05-01), Oballa et al.
patent: WO 97 09315 (1997-03-01), None
patent: WO 03 020278 (2003-03-01), None
patent: WO 03 020287 (2003-03-01), None
patent: WO 03 020721 (2003-03-01), None
Wang et al., International Journal of Pharmaceutics, 277, pp. 73-79, 2004.
Simone, Oncology: Introduction, Cecil Textbook of Medicine, 20m edition, vol. 1, pp. 1004-1010, 1996.
Wolff Manfred E. “Burger's Medicinal Chemistry, 5ed, Part 1”, John Wiley & Sons, 1995, pp. 975-977.
Banker, G.S. et al, “Modern Pharmaceutics, 3ed.”, Marcel Dekker, New York. 1996, pp. 451 and 596.
Hou et al., Arthritis & Rheumatism, 46(3), 663-674, 2002.
Caravatti et al., Bioorg. Med. Chem. Lett., 9, 1973-1978, 1999.
Katoh et al., WO 2003/016266; CA 138: 205074, 2003.
Chemical Abstracts: 131:266564, Registry No. 245321-46-4, 1999.
Chemical Abstracts 125:300908, Registry No. 99973-07-6, 1996.
Chemical Abstracts 94:208812, Registry Nos. 77768-07-1, 77768-06-0 and 77768-05-9, 1981.
Chemical Abstracts 77:139962, Registry No. 37920-78-8, 1972.
Chemical Abstracts 60: 52751, Registry Nos. 92023-78-4 and 91396-87-1, 1964.
Chemical Abstracts 53: 21997f, Registry No. 105402-10-6, 1959.
Altmann Eva
Betschart Claudia
Hayakawa Kenji
Irie Osamu
Iwasaki Genji
Alexander John
Balasubramanian Venkataraman
Novartis AG
LandOfFree
Hetereoaryl nitrile derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hetereoaryl nitrile derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hetereoaryl nitrile derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4128765